GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Nanosphere Inc (NAS:NSPH) » Definitions » 3-Year Revenue Growth Rate

Nanosphere (Nanosphere) 3-Year Revenue Growth Rate : 0.00% (As of Mar. 2016)


View and export this data going back to 2007. Start your Free Trial

What is Nanosphere 3-Year Revenue Growth Rate?

Nanosphere's Revenue per Share for the three months ended in Mar. 2016 was $0.54.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Competitive Comparison of Nanosphere's 3-Year Revenue Growth Rate

For the Diagnostics & Research subindustry, Nanosphere's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nanosphere's 3-Year Revenue Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Nanosphere's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Nanosphere's 3-Year Revenue Growth Rate falls into.



Nanosphere 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Nanosphere  (NAS:NSPH) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


Nanosphere 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Nanosphere's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Nanosphere (Nanosphere) Business Description

Traded in Other Exchanges
N/A
Address
Nanosphere, Inc., was incorporated in 1999 in Delaware. The Company develops, manufactures and markets an advanced molecular diagnostics platform, the Verigene System, that enables sensitive genomic and protein testing on a single platform. The Verigene System includes a bench-top molecular diagnostics workstation that is an advanced platform for genomic and protein testing. The Verigene System includes a bench-top molecular diagnostics workstation that is a universal platform for genomic and protein testing. The Verigene System provides lower cost for laboratories already performing molecular diagnostic testing and enables smaller laboratories and hospitals without advanced diagnostic capabilities to perform genetic testing.
Executives
Michael James Ward director 440 W. ONTARIO ST., CHICAGO IL 60654
Lorin Randall director C/O ACORDA THERAPEUTICS, INC., 420 SAW MILL RIVER ROAD, ARDSLEY NY 10502
R. Erik Holmlin director 4088 COMMERCIAL AVE., NORTHBROOK IL 60062
Gene S Cartwright director 4088 COMMERCIAL AVE, NORTHBROOK IL 60062
Mmcap International Inc. Spc 10 percent owner C/O MOURANT GOVERNANCE SVCS (CAYMAN) LTD, 94 SOLARIS AVE., CAMANA BAY, PO BOX 1348, GRAND CAYMAN E9 KY1-1108
Ann Wallin officer: Interim CFO 4088 COMMERCIAL AVENUE, NORTHBROOK IL 60062
Bruin Andre De director
Sheli Z Rosenberg director C/O EQUITY GROUP INVESTMENTS, L.L.C., TWO NORTH RIVERSIDE PLAZA, SUITE 600, CHICAGO IL 60606
Chad A. Mirkin director 4088 COMMERCIAL AVENUE, NORTHBROOK IL 60062
Brookside Capital Management Llc 10 percent owner C/O BAIN CAPITAL PUBLIC EQUITY, LP, 200 CLARENDON STREET, BOSTON MA 02116
Brookside Capital Partners Fund Lp 10 percent owner C/O BAIN CAPITAL PUBLIC EQUITY, LP, 200 CLARENDON STREET, BOSTON MA 02116
Brookside Capital Investors L P 10 percent owner C/O BAIN CAPITAL PUBLIC EQUITY, LP, 200 CLARENDON STREET, BOSTON MA 02116
Bain Capital Venture Fund 2005, L.p. 10 percent owner C/O BAIN CAPITAL, LLC, JOHN HANCOCK TOWER, 200 CLARENDON STREET, BOSTON MA 02116
Bain Capital Venture Partners 2005, L.p. 10 percent owner C/O BAIN CAPITAL, LLC, JOHN HANCOCK TOWER, 200 CLARENDON STREET, BOSTON MA 02116
Bain Capital Venture Investors, Llc 10 percent owner 200 CLARENDON STREET, BOSTON MA 02116

Nanosphere (Nanosphere) Headlines

From GuruFocus

NANOSPHERE, INC. Reports Operating Results (10-Q)

By gurufocus 10qk 08-05-2010

NANOSPHERE, INC. Reports Operating Results (10-Q)

By gurufocus 10qk 05-06-2010

New Optical Disks May Boost the Gold Nanoparticles Industry

By Alberto Abaterusso Alberto Abaterusso 03-27-2018

NANOSPHERE, INC. Reports Operating Results (10-Q)

By gurufocus 10qk 11-05-2009